Free Trial

Ironwood Pharmaceuticals (IRWD) News Today

Ironwood Pharmaceuticals logo
$0.78 -0.02 (-2.90%)
As of 09:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IRWD Latest News

Ironwood Raises 2025 Adj. EBITDA Outlook
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
Ironwood Pharma (IRWD) was downgraded to a Hold Rating at Craig-Hallum
Ironwood downgraded to Hold from Buy at Jefferies
Get Ironwood Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter.

IRWD Media Mentions By Week

IRWD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IRWD
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

IRWD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IRWD Articles
This Week

0

4

IRWD Articles
Average Week

Get Ironwood Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IRWD) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners